SVA - Sinovac BiotechAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $6.47 | Open | |
| Volume | Market Cap | 460.25M | |
| Yield | Last Dividend |
| DOH: Sinovac trials in PH to push throug... | 1:49 AM |
| https://www.youtube.com/watch?v=cJz5pFt6hWM MANILA, Philippines --- CoronaVac, the Covid-19 vaccine candidate of China's Sinovac Biotech, will be used... | |
| Brazil battles Chinese red tape to get k... | 01/19/21 |
| Brazil is battling bureaucracy in China to free up exports of active ingredients for vaccines developed by AstraZeneca and Sinovac Biotech, three peop... | |
| ???An industry practice,??? Duterte says... | 01/18/21 |
| MANILA, Philippines --- President Rodrigo Duterte defended in his weekly taped briefing on Monday the reluctance of government officials to disclose t... | |
| Duterte vouches for Galvez: Why focus on... | 01/18/21 |
| MANILA, Philippines --- President Rodrigo Duterte vouched for the government's national COVID-19 vaccination plan on Monday, questioning critics why t... | |
| Sinovac says Covid-19 vaccine efficacy i... | 01/18/21 |
| A Covid-19 vaccine developed in China has been shown to be 20 percent more effective in a small clinical trial group when doses are given three weeks ... | |
| Senate sets 3rd hearing on government???... | 01/18/21 |
| MANILA, Philippines --- The Senate Committee of the Whole will resume its public hearing into the government's Covid-19 vaccination plan on Friday, Ja... | |
| Lacson smells ???attempt to overprice???... | 01/18/21 |
| MANILA, Philippines --- Senator Panfilo Lacson has hinted of a possible "attempt to overprice" by roughly P16.8 billion the Philippine government's pr... | |
| Coronavirus: India reports 13,788 new ca... | 01/17/21 |
| Brazil gave emergency-use approval to vaccines developed by Oxford-AstraZeneca vaccine and China???s Sinovac Biotech. | |
| Sinovac: PH got reasonable deal for Covi... | 01/17/21 |
| MANILA, Philippines --- China's Sinovac Biotech's vaccine against COVID-19 is not the most expensive and was sold at a "very good price" to the Philip... | |
| Live: Brazil approves emergency use of C... | 01/17/21 |
| Brazil's health regulators approve coronavirus vaccines from China's Sinovac Biotech and Britain's Oxford-Astrazeneca for emergency use. Follow live. | |
| Brazil approves two coronavirus vaccines | 01/17/21 |
| Brazil's health regulator has approved the emergency use of COVID-19 vaccines from China's Sinovac Biotech and Britain's AstraZeneca. | |
| ?????????????????????"It Is Extremely Wr... | 01/16/21 |
| ?????????????????????"It Is Extremely Wrong" - Turkey Bargains Extradition Of Uighurs For China Vaccine Even though scientists in Brazil have downgrad... | |
| Sinovac Biotech : Indonesia reports reco... | 01/16/21 |
| Indonesia reported a record daily increase in COVID-19 cases with 14,224 new infections, its COVID-19 task force said on Saturday, bringing the total ... | |
| British Crown Agents to buy COVID-19 vac... | 01/15/21 |
| Ukraine has signed a contract with U.K. company Crown Agents for the purchase of coronavirus vaccine produced by Chinese company Sinovac Biotech, Ukra... | |
| Sinovac vaccines offered at ???BFF price... | 01/14/21 |
| MANILA ??? The coronavirus disease 2019 (Covid-19) vaccines developed by China???s Sinovac Biotech Ltd. were sold to the Philippines at a ??? | |
| ???Presyong BFF???: Palace assures Sinov... | 01/14/21 |
| The COVID-19 vaccine developed by China???s Sinovac Biotech is not the most expensive since the Philippines was given a "BFF" rate. | |
| Instagram influencers are a vaccine prio... | 01/14/21 |
| Jakarta, January 14 Among the first in the queue for coronavirus vaccines in Indonesia has been one conspicuous group - social media influencers. Alon... | |
| President Joko Widodo Becomes First Indo... | 01/13/21 |
| Indonesian President Joko Widodo received the Covid-19 vaccine shot developed by China's biopharmaceutical company Sinovac Biotech. | |
| Galvez: Gov???t chose Sinovac vaccine be... | 01/13/21 |
| Vaccine czar Carlito Galvez Jr. defended on Wednesday the government???s decision to procure vaccines developed by China???s Sinovac Biotech. | |
| Turkey approves China-based Sinovac vacc... | 01/13/21 |
| ANKARA, Turkey (AP) ??? Turkish authorities gave the go-ahead for the emergency use of the COVID-19 vaccine produced by China???s Sinovac Biotech Ltd.... | |
| Malaysia will only go ahead with Sinovac... | 01/13/21 |
| Malaysia, which is negotiating supplies of a COVID-19 vaccine with China???s Sinovac Biotech, will only go ahead with procurement if it satisfies the ... | |
| Health Ministry Expecting Final Results ... | 01/13/21 |
| The Health Ministry is expecting final results of researching of the vaccine against the Covid-19 produced by Sinovac Biotech (the People's Republic o... | |
| Chinese Covid-19 vaccine far less effect... | 01/13/21 |
| A leading Chinese Covid-19 vaccine developed by Sinovac Biotech was just 50.38% effective in late-stage trials in Brazil, significantly lower than ear... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
